Trial Profile
Transcription and protein profiling of whole blood and serum from natalizumab treated patients with developed progressive multifocal leukoencephalopathy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 May 2015
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 27 May 2015 New trial record